Rational Fluid Therapy in Germany

• Conditions: Patients in ICU

• Registration Number: NCT01122277
• Lead Sponsor: Ludwig-Maximilians - University of Munich

Brief Summary

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

Detailed Description

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany.

Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Study Timeline

• Study Start: 2010-05
• Study First Submitted: 2010-05-11
• Study First Submitted QC: 2010-05-12
• Study First Posted: 2010-05-13
• Status Verified: 2010-10
• Primary Completion: 2011-05
• Last Update Submitted: 2011-07-07
• Last Update Posted: 2011-07-08
• Study Completion: 2011-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 4000

Inclusion Criteria

• ICU patients with an indication for fluid/volume therapy

Exclusion Criteria

• Patients hospitalized by order of a court of law or a government agency

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (2)

Universitätsklinikum Münster; 🇩🇪 Münster, Nordrhein - Westfalen, Germany

Klinik für Anaesthesiologie, Klinikum der Universität München; 🇩🇪 Munich, Bavaria, Germany